SCHEMBL31672348

SCHEMBL31672348

C=CC(=O)N1CC(N2CCN(C(=O)CNc3cc(O)c(Cl)cc3Cl)CC2)C1

nearest known ligand 0.79

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 17/20 0.79
▸ EGLN1 Q9GZT9 1/20 0.35
▸ JAK3 P52333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16117849 1.00 KRAS (0.79) KRASEGLN1JAK3
SCHEMBL31672385 0.92 KRAS (0.84) KRAS
SCHEMBL16117848 0.92 KRAS (0.84) KRAS
SCHEMBL16103039 0.88 KRAS (1.00) KRASEGLN1
SCHEMBL31672334 0.88 KRAS (1.00) KRASEGLN1
SCHEMBL16117836 0.86 KRAS (0.67) KRASJAK3
SCHEMBL30642315 0.86 KRAS (0.67) KRASJAK3
SCHEMBL16117831 0.86 KRAS (0.67) KRASJAK3
SCHEMBL31672345 0.86 KRAS (0.67) KRASJAK3
SCHEMBL16117858 0.85 KRAS (0.85) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50527-E1 Covalent inhibitors of KRAS G12C ARAXES PHARMA LLC (US) 2025-08-12 — — US disclosed
Send feedback